More than 500,000 annual liver cancer diagnoses could be prevented with global interventions aimed at reducing viral hepatitis B and C, alcohol consumption and a disease strongly associated with ...

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease.

License agreement supports Madrigal's pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra (resmetirom) Combining Rezdiffra with the ...

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...

DelveInsight's THR-β Agonist Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable patient ...

A large new study links a rise in liver disease in the U.S. to increased alcohol consumption — and women are especially affected.

Madrigal Pharmaceuticals secures global rights to SYH2086, aiming to enhance MASH treatment with innovative combination ...

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease.

New research has identified cholesterol accumulation as a key molecular trigger of fibrosis in metabolic disease.

The gut is home to trillions of microbes, which can have a wide range of impacts on human health in various ways. These ...

Fatty liver disease is one of the fastest-growing health concerns worldwide, impacting roughly 32% of people worldwide, according to a 2022 systematic review. It is closely tied to rising rates of ...